Concepedia

Clint A. Stalnecker

CA

Statistics

Publications

17

Citations

4.4K

H-Index

16

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

Cornell University

George Mason University

Harvard University

Dana-Farber Cancer Institute

Clint A. Stalnecker is an author at University of North Carolina at Chapel Hill specializing in molecular oncology, oncology, and life sciences.

ORCID

Publications per year

2014–2025

17

Publications

17

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>

Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah et al. · Autophagy · 2021 · 2.6K citations · Full text

, , +9

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 715 citations

, , +16

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text

, , +17

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text

, , +17

SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis

Kai Su Greene, Michael J. Lukey, Xueying Wang et al. · Proceedings of the National Academy of Sciences · 2019 · 136 citations · Full text

, , +17

1–5 of 17